Aria Diagnostics Obtains $52,700,000 Series C Financing
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=3df2370b-c5ec-4635-9504-a41d1d6fcab8&Preview=1 -
Date
1/10/2012 -
Company Name
Aria Diagnostics -
Mailing Address
5945 Optical Court San Jose, CA 95138 -
Company Description
Aria Diagnostics is a privately funded biotechnology company based on a strong scientific foundation. Our novel blood tests equip pregnant women with the right information to make decisions regarding the health of their baby and their own body. -
Website
http://www.ariadx.com -
Transaction Type
Venture Equity -
Transaction Amount
$52,700,000 -
Transaction Round
Series C -
Proceeds Purposes
Aria will use the funds to support product development and prepare commercialization of its proprietary prenatal test to detect common fetal trisomies such as Trisomy 21, which is associated with Down syndrome. -
M&A Terms
-
Venture Investor
Meritech Capital Partners -
Venture Investor
Venrock -
Venture Investor
Domain Associates
